METHODS	Of 19342 hypertensive patients ( aged 40-79 years with at least three other cardiovascular risk factors ) randomised to one of two antihypertensive regimens in the Anglo-Scandinavian Cardiac Outcomes Trial , 10305 with non-fasting total cholesterol concentrations 6.5 mmol/L or less were randomly assigned additional atorvastatin 10 mg or placebo .\